A new trading day began on Friday, with Korro Bio Inc (NASDAQ: KRRO) stock price down -6.82% from the previous day of trading, before settling in for the closing price of $14.81. KRRO’s price has ranged from $11.13 to $98.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -26.84%. Meanwhile, its annual earnings per share averaged -0.98%. With a float of $5.49 million, this company’s outstanding shares have now reached $9.39 million.
Let’s determine the extent of company efficiency that accounts for 104 employees. In terms of profitability, gross margin is 62.17%, operating margin of -1980.44%, and the pretax margin is -1810.56%.
Korro Bio Inc (KRRO) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Korro Bio Inc is 41.54%, while institutional ownership is 72.03%. The most recent insider transaction that took place on Nov 11 ’24, was worth 56,000. In this transaction Chief Financial Officer of this company sold 800 shares at a rate of $70.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Officer proposed sale 800 for $70.00, making the entire transaction worth $56,000.
Korro Bio Inc (KRRO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -0.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.45% during the next five years compared to 21.83% growth over the previous five years of trading.
Korro Bio Inc (NASDAQ: KRRO) Trading Performance Indicators
Here are Korro Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 26.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.44, a number that is poised to hit -2.57 in the next quarter and is forecasted to reach -8.89 in one year’s time.
Technical Analysis of Korro Bio Inc (KRRO)
Looking closely at Korro Bio Inc (NASDAQ: KRRO), its last 5-days average volume was 63840.0, which is a drop from its year-to-date volume of 89920.0. As of the previous 9 days, the stock’s Stochastic %D was 25.83%. Additionally, its Average True Range was 1.96.
During the past 100 days, Korro Bio Inc’s (KRRO) raw stochastic average was set at 8.29%, which indicates a significant decrease from 8.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 111.36% in the past 14 days, which was higher than the 102.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.89, while its 200-day Moving Average is $35.98. However, in the short run, Korro Bio Inc’s stock first resistance to watch stands at $14.43. Second resistance stands at $15.05. The third major resistance level sits at $15.40. If the price goes on to break the first support level at $13.45, it is likely to go to the next support level at $13.10. Now, if the price goes above the second support level, the third support stands at $12.48.
Korro Bio Inc (NASDAQ: KRRO) Key Stats
With a market capitalization of 129.59 million, the company has a total of 9,391K Shares Outstanding. Currently, annual sales are 2,270 K while annual income is -83,580 K. The company’s previous quarter sales were 2,550 K while its latest quarter income was -23,390 K.
